Fujifilm releases Synapse 5 in U.S.

Fujifilm Medical Systems U.S.A. announced Thursday that it has officially released Synapse 5, the latest version of its Synapse PACS solution, in the United States. The company says Synapse 5 “sets new standards for enterprise imaging” and it is available now.

Bill Lacy, Fujifilm Medical Systems U.S.A. vice president of medical informatics, said in a prepared statement that this latest version should appeal to both new customers and longtime users of the company’s PACS solutions.

“Highly functional software designed to streamline workflow, along with speed and precision, are what practices and healthcare systems across the country need to collaborate and deliver the best possible patient care,” he said. “Synapse 5 offers a transformational enterprise imaging opportunity for new customers, while providing unprecedented value to our existing PACS customers, many of whom have been using Synapse PACS for 18 years.”

Server-based image rendering and a zero-download viewer are two specific Synapse 5 features the company highlighted in its statement.

Michael Walter
Michael Walter, Managing Editor

Michael has more than 18 years of experience as a professional writer and editor. He has written at length about cardiology, radiology, artificial intelligence and other key healthcare topics.

Around the web

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.

CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.

The all-in-one Omni Legend PET/CT scanner is now being manufactured in a new production facility in Waukesha, Wisconsin.